Cellular Blueprint of Multiple Sclerosis Potentiate New Therapies

Cellular blueprint of multiple sclerosis lesions lays the groundwork for potential new therapies for progressive multiple sclerosis.

Cellular blueprint of multiple sclerosis lesions has been developed by scientist at the NIH/National Institute Of Neurological Disorders And Stroke. This lays the groundwork for potential new therapies for progressive multiple sclerosis as per their study “A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis” , published in Nature.

Multiple sclerosis (MS) is a demyelinating autoimmune neurological condition that commonly affects the myelin sheath (outer fatty cover of nerves) of the peripheral nervous system, brain, and spinal cord.

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

‘Cellular blueprint of multiple sclerosis lesions lays the groundwork for potential new therapies for progressive multiple sclerosis. ’

It results in a range of incapacitating symptoms that differ from one person to another such as unsteadiness, blurred vision, tingling sensations, memory problems, and fatigue.

The more aggressive and disabling forms of the disease are characterized by chronic lesions with inflamed rims of immune cells (called microglia) or “smoldering” plaques, in the brains of MS people.

Cellular Blueprint

Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.

The study team thus examined the post-mortem brain tissue of five MS patients and three healthy controls through a powerful technique – single-cell RNA sequencing.

“We have terrific therapies that block new inflammation but nothing to stop the inflammation that’s already there. In order to make strides in developing new therapies for progressive MS, we’re going to need to pick apart the cellular and molecular mechanisms one by one,” says Daniel Reich, M.D., Ph.D., senior investigator at NINDS.

Multiple Sclerosis may Cause Myriad of Symptoms
People with newly diagnosed multiple sclerosis are found to experience a myriad of significant symptoms that often cluster together.

By analyzing the gene activity profiles of over 66,000 cells from human brain tissue, the team built a detailed cellular map of chronic MS lesions, thereby identifying genes that play a critical role in lesion repair and revealing potential new therapeutic targets for progressive MS.

“Our dataset is very rich. The beauty of having such a detailed map is that now we have a better understanding of the entire network of cells involved in smoldering inflammation,” said Martina Absinta, M.D., Ph.D., a former post-doctoral fellow in Dr. Reich’s lab and current adjunct assistant professor at Johns Hopkins University, Baltimore, who led the study.

New Research Reveals Why Multiple Sclerosis (MS) Patients Develop Progressive Disability
The scars in the brain and spinal cord of people with multiple sclerosis offer clues to why they developprogressive disability, reveals new study.

Source-Medindia